journal article·2022-09-27Open access

Silver and Hyaluronic Acid-Coated Gold Nanoparticles Modulate the Metabolism of a Model Human Gut Bacterium Lactobacillus casei

Wenqian Huang, Yirong Zhang, Zhi Li, Minjie Li, Fangfang Li, Monika Mortimer, Liang-Hong Guo

Nanomaterials· Volume 12· Issue 19

Abstract

Medical applications of nanotechnology are promising in creating efficient and targeted therapies. However, so far, nanodrug design has not taken into consideration possible effects on human microbiota. The beneficial functions of bacteria could be stimulated by nanodrugs while negative effects on beneficial bacteria could cause risks to human health. Here, simulated intestinal fluid (IF) was optimized for culturing a human commensal and probiotic bacterial strain, Lactobacillus casei, to study the effects of medically relevant NPs—Ag and hyaluronic acid-coated Au NPs (HA-Au NPs)—in conditions pertinent to the gastrointestinal tract. When cultivated either aerobically or anaerobically, the specific growth rates of L. casei were ~0.2 h−1 in IF and ~0.4 h−1 in the standard medium of lactobacilli (MRS). Ag NPs inhibited the growth of L. casei in IF at lower concentrations (EC50 ~ 65 and 15 mg/L in aerobic and anaerobic conditions, respectively) than in MRS (EC50 > 100 mg/L), likely caused by differences in the composition of the two media and different intrinsic growth rates of bacteria in IF and MRS. Ag NP dissolution in IF and MRS did not explain the differences in growth inhibition, implying NP-specific effects. HA-Au NPs were not growth-inhibitory to L. casei up to 250 mg/L. Still, both NPs at sub-growth-inhibitory concentrations suppressed the expression of bacteriocin genes in L. casei, suggesting an inhibitory effect of NPs on the probiotic properties of L. casei, i.e., its competitiveness in microbial communities. However, HA-Au NPs did not appear to affect or even stimulated the immunomodulatory properties of L. casei in human intestinal epithelial cells. Thus, medically relevant NPs at low, sub-bacteriostatic levels can affect the metabolism of beneficial human bacteria and potentially induce changes in the microbiota and immune signaling.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Probiotics and Fermented Foods · Proteins in Food Systems · Gut microbiota and health

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Life Science, China Jiliang University, Hangzhou 310018, China 2 Institute of Environmental and Health Sciences, China Jiliang University, Hangzhou 310018, China 3 College of Quality and Safety Engineering, China Jiliang University, Hangzhou 310018, China

Institute of Environmental and Health Sciences, China Jiliang University, Hangzhou 310018, China

College of Quality and Safety Engineering, China Jiliang University, Hangzhou 310018, China

Funding

National Natural Science Foundation of China · Key Laboratory of Biomedical Effects of Nanomaterials and Nanosafety, Chinese Academy of Sciences

References (71)

Show source-provided references
1. Implications of the Human Gut-Brain and Gut-Cancer Axes for Future Nanomedicine10.1021/acsnano.0c07258 ↗
2. Nanomedicine in China10.1002/adhm.201801051 ↗
3. Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date10.1007/s11095-016-1958-5 ↗
4. A Safe-by-Design Strategy towards Safer Nanomaterials in Nanomedicines10.1002/adma.201805391 ↗
5. Kim, K., Choi, H., Choi, E.S., Park, M.-H., and Ryu, J.-H. (2019). Hyaluronic Acid-Coated Nanomedicine for Targeted Cancer Therapy. Pharmaceutics, 11.10.3390/pharmaceutics11070301 ↗
6. Hyaluronic acid-bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis10.1038/s41563-019-0462-9 ↗
7. Antibacterial nanomaterials for environmental and consumer product applications10.1016/j.impact.2020.100268 ↗
8. Silver Prussian Blue Analogue Nanoparticles: Rationally Designed Advanced Nanomedicine for Multifunctional Biomedical Applications10.1021/acsbiomaterials.9b01693 ↗
9. Interplay between engineered nanomaterials and microbiota10.1039/D0EN00557F ↗
10. Effects of subchronic exposure of silver nanoparticles on intestinal microbiota and gut-associated immune responses in the ileum of Sprague-Dawley rats10.3109/17435390.2014.921346 ↗
11. The effects of orally administered Ag, TiO2 and SiO2 nanoparticles on gut microbiota composition and colitis induction in mice10.1016/j.impact.2017.07.005 ↗
12. Orally administered gold nanoparticles protect against colitis by attenuating Toll-like receptor 4- and reactive oxygen/nitrogen species-mediated inflammatory responses but could induce gut dysbiosis in mice10.1186/s12951-018-0415-5 ↗
13. Commensal bacteria mediated defenses against pathogens10.1016/j.coi.2014.03.003 ↗
14. Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells10.4049/jimmunol.176.2.1228 ↗
15. Innate immune recognition at the epithelial barrier drives adaptive immunity: APCs take the back seat10.1016/j.it.2007.10.002 ↗
16. Multiwall Carbon Nanotubes Induce More Pronounced Transcriptomic Responses in Pseudomonas aeruginosa PG201 than Graphene, Exfoliated Boron Nitride, or Carbon Black10.1021/acsnano.7b08977 ↗
17. Physical Properties of Carbon Nanomaterials and Nanoceria Affect Pathways Important to the Nodulation Competitiveness of the Symbiotic N2-Fixing Bacterium Bradyrhizobium diazoefficiens10.1002/smll.201906055 ↗
18. Nanotoxicology and nanomedicine: The Yin and Yang of nano-bio interactions for the new decade10.1016/j.nantod.2021.101184 ↗
19. Core-Shell HA-AuNPs@SiNPs Nanoprobe for Sensitive Fluorescence Hyaluronidase Detection and Cell Imaging10.1021/acssuschemeng.8b03684 ↗
20. NIH Image to ImageJ: 25 years of image analysis10.1038/nmeth.2089 ↗
21. A synthetic medium for comparative nutritional studies of lactobacilli10.1111/j.1365-2672.1977.tb00676.x ↗
22. A standardised static in vitro digestion method suitable for food—An international consensus10.1039/C3FO60702J ↗
23. Negligible Particle-Specific Antibacterial Activity of Silver Nanoparticles10.1021/nl301934w ↗
24. Uptake and depuration of carbon- and boron nitride-based nanomaterials in the protozoa Tetrahymena thermophila10.1039/D1EN00750E ↗
25. Vindimian, E. (2022, May 01). MSExcel Macro REGTOX EV7.0.5.xls. Available online: http://www.normalesup.org/~vindimian/en_download.html.
26. Characterization of putative class II bacteriocins identified from a non-bacteriocin-producing strain Lactobacillus casei ATCC 33410.1007/s00253-012-4149-2 ↗
27. A new mathematical model for relative quantification in real-time RT-PCR10.1093/nar/29.9.e45 ↗
28. Use of the Soft-agar Overlay Technique to Screen for Bacterially Produced Inhibitory Compounds
29. A medium for the cultivation of Lactobacilli10.1111/j.1365-2672.1960.tb00188.x ↗
30. Cultivation media for lactic acid bacteria used in dairy products10.1017/S002202991900075X ↗
31. Enhancement of bile tolerance in lactococci by Tween 8010.1046/j.1365-2672.2002.01505.x ↗
32. The Lactobacillus Bile Salt Hydrolase Repertoire Reveals Niche-Specific Adaptation10.1128/mSphere.00140-18 ↗
33. Lactic acid bacteria contribution to gut microbiota complexity: Lights and shadows10.3389/fcimb.2012.00086 ↗
34. Aggregation-Dependent Oxidation of Metal Nanoparticles10.1021/jacs.7b05957 ↗
35. Protein corona-induced modification of silver nanoparticle aggregation in simulated gastric fluid10.1039/C6EN00278A ↗
36. Extracellular conversion of silver ions into silver nanoparticles by protozoan Tetrahymena thermophila10.1039/C2EM30731F ↗
37. Interaction of firefly luciferase and silver nanoparticles and its impact on enzyme activity10.1088/0957-4484/24/34/345101 ↗
38. One-pot synthesis of hyaluronic acid-coated gold nanoparticles as SERS substrate for the determination of hyaluronidase activity10.1007/s00604-020-04566-3 ↗
39. Influences of simulated gastrointestinal environment on physicochemical properties of gold nanoparticles and their implications on intestinal epithelial permeability10.1080/10590501.2019.1602994 ↗
40. Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: Applications in biological imaging and biomedicine10.1021/jp057170o ↗
41. Shannahan, J.H., Lai, X.Y., Ke, P.C., Podila, R., Brown, J.M., and Witzmann, F.A. (2013). Silver Nanoparticle Protein Corona Composition in Cell Culture Media. PLoS ONE, 8.10.1371/journal.pone.0074001 ↗
42. Methods for Extraction of Muscle Proteins from Meat and Fish Using Denaturing and Nondenaturing Solutions10.1155/2018/8478471 ↗
43. Secreted Biomolecules Alter the Biological Identity and Cellular Interactions of Nanoparticles10.1021/nn4061012 ↗
44. Bactericidal Effects of Silver Nanoparticles on Lactobacilli and the Underlying Mechanism10.1021/acsami.7b17274 ↗
45. Toxicity mechanisms in Escherichia coli vary for silver nanoparticles and differ from ionic silver10.1021/nn4044047 ↗
46. Ivask, A., Kurvet, I., Kasemets, K., Blinova, I., Aruoja, V., Suppi, S., Vija, H., Käkinen, A., Titma, T., and Heinlaan, M. (2014). Size-Dependent Toxicity of Silver Nanoparticles to Bacteria, Yeast, Algae, Crustaceans and Mammalian Cells In Vitro. PLoS ONE, 9.10.1371/journal.pone.0102108 ↗
47. Bondarenko, O., Ivask, A., Kakinen, A., Kurvet, I., and Kahru, A. (2013). Particle-cell contact enhances antibacterial activity of silver nanoparticles. PLoS ONE, 8.10.1371/journal.pone.0064060 ↗
48. Impacts of gold nanoparticle charge and ligand type on surface binding and toxicity to Gram-negative and Gram-positive bacteria10.1039/C5SC00792E ↗
49. Derivation of guideline values for gold (III) ion toxicity limits to protect aquatic ecosystems10.1016/j.watres.2013.09.019 ↗
50. A general mechanism for intracellular toxicity of metal-containing nanoparticles10.1039/c4nr01234h ↗
51. Gold Nanoparticles Dissolve Extracellularly in the Presence of Human Macrophages10.2147/IJN.S314643 ↗
52. Unexpected intracellular biodegradation and recrystallization of gold nanoparticles10.1073/pnas.1911734116 ↗
53. Influence of culture media, pH and temperature on growth and bacteriocin production of bacteriocinogenic lactic acid bacteria10.1186/s13568-018-0536-0 ↗
54. Novel method to extract large amounts of bacteriocins from lactic-acid bacteria10.1128/aem.58.10.3355-3359.1992 ↗
55. A new way of producing pediocin in Pediococcus acidilactici through intracellular stimulation by internalized inulin nanoparticles10.1038/s41598-018-24227-z ↗
56. Pullulan Nanoparticles as Prebiotics Enhance the Antibacterial Properties of Lactobacillus plantarum Through the Induction of Mild Stress in Probiotics10.3389/fmicb.2019.00142 ↗
57. Effects of sublethal doses of silver nanoparticles on Bacillus subtilis planktonic and sessile cells10.1111/jam.12779 ↗
58. Label-Free Proteomic Approach to Study the Non-lethal Effects of Silver Nanoparticles on a Gut Bacterium10.3389/fmicb.2019.02709 ↗
59. Towards a better understanding of Pseudomonas putida biofilm formation in the presence of ZnO nanoparticles (NPs): Role of NP concentration10.1016/j.envint.2020.105485 ↗
60. Nanosilver Mitigates Biofilm Formation via FapC Amyloidosis Inhibition10.1002/smll.201906674 ↗
61. Exploring the applications of hyaluronic acid-based nanoparticles for diagnosis and treatment of bacterial infections10.1002/wnan.1799 ↗
62. Di Cerbo, A., Aponte, M., Esposito, R., Bondi, M., and Palmieri, B. (2013). Comparison of the effects of hyaluronidase and hyaluronic acid on probiotics growth. BMC Microbiol., 13.10.1186/1471-2180-13-243 ↗
63. The Lactobacillus casei Group: History and Health Related Applications10.3389/fmicb.2018.02107 ↗
64. Interaction of lactic acid bacteria with the gut immune system10.1038/sj.ejcn.1601658 ↗
65. Immunomodulatory Effect of Lactobacillus casei in a Murine Model of Colon Carcinogenesis10.1007/s12602-019-09611-z ↗
66. Intestinal barrier dysfunction orchestrates the onset of inflammatory host-microbiome cross-talk in a human gut inflammation-on-a-chip10.1073/pnas.1810819115 ↗
67. Magneto-optical hyperthermia agents based on probiotic bacteria loaded with magnetic and gold nanoparticles10.1039/D1NR08513A ↗
68. Emerging investigator series: It’s not all about the ion: Support for particle-specific contributions to silver nanoparticle antimicrobial activity10.1039/C8EN00429C ↗
69. Antimicrobial Activity of Gold Nanoparticles and Ionic Gold10.1080/10590501.2015.1055161 ↗
70. Molecular Mechanisms of Nanomaterial-Bacterial Interactions Revealed by Omics-The Role of Nanomaterial Effect Level10.3389/fbioe.2021.683520 ↗
71. Preclinical hazard evaluation strategy for nanomedicines10.1080/17435390.2018.1505000 ↗